USMJ To Meet With ALYI and LEXG Later This Week In Phoenix On Lithium Technology And Cannabis Point of Sale System

DALLAS, TX - June 13, 2017 - InvestorsHub NewsWire - North American Cannabis Holdings, Inc. (OTC PINK: USMJ) recently announced a deal shift in the planned transaction with Alternet Systems, Inc. (USOTC:ALYI) in conjunction with the acquisition of the controlling interest in USMJ by American Cannabis Innovations Conglomerated ("ACI"). The ACI acquisition is part of ACI's overall strategy to acquire early stage, undervalued businesses with intellectual properties validated by market tests, and commercial or consumer sales. USMJ plans to acquire ALYI’s Point of Sale (POS) technology to further develop and market test a Cannabis Industry specific POS.  USMJ had previously planned to maintain the POS technology within ALYI and orchestrate an equity swap between the two Companies. Alternatively, ALYI has entered into an agreement to go a different direction acquiring a private Lithium Intellectual Property Company that has entered into a strategic agreement with Lithium Exploration Group, Inc. (USOTC:LEXG), among other strategic developments.  USMJ, ALYI and LEXG will all meet later this week near LEXG’s home city of operation in Phoenix, AZ.
 
Learn More About USMJ: growusmj.com
 
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
 
North American Cannabis Holdings Contact:
Steven Rash 
Phone: [phone] 
Email: [e-mail]